- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03672344
Computer-based Social Skills Training for Autism Spectrum Disorder
June 22, 2022 updated by: BioStream Technologies, LLC
The primary objective of this study is to evaluate changes in subject performance on social skills assessments after engaging in a gaze-controlled video game that leverages ABA principles of learning, in comparison to an alternative game.
The secondary objectives of this study are to evaluate changes in subject gaze patterns during social skills assessments after engaging in the video game, including in comparison to an alternative game and to evaluate possible correlations in changes in social skills assessments with changes in subject game play performance.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
Orange, Connecticut, United States, 06477
- Milestones Behavioral Services
-
-
Florida
-
Jupiter, Florida, United States, 33458
- Els for Autism Foundation
-
Melbourne, Florida, United States, 32901
- Positive Behavior Supports Corporation
-
Miami, Florida, United States, 33173
- Positive Behavior Supports Corporation
-
West Palm Beach, Florida, United States, 33409
- Positive Behavior Supports Corporation
-
-
Massachusetts
-
Bedford, Massachusetts, United States, 01730
- Nashoba Learning Group, Inc.
-
-
New Jersey
-
Cherry Hill, New Jersey, United States, 08002
- Y.A.L.E. School
-
Cherry Hill, New Jersey, United States, 08003
- Connect Plus Therapy, Inc.
-
Clementon, New Jersey, United States, 08021
- Partners in Learning, Inc.
-
Point Pleasant Beach, New Jersey, United States, 08742
- Mary E. Keefe
-
-
Pennsylvania
-
Jeffersonville, Pennsylvania, United States, 19403
- The Pathway School
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 14 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ages 4-14.
- Meets diagnostic criteria for ASD.
- Estimated intelligence standard score of at least 40 (can be substituted for a receptive language score such as PPVT or use of the Differential Ability Scales, 2nd Edition (DAS-II)).
- Parent reports difficulty with at least one of two social skills (via modified questions from the Social Responsiveness Scale)
- English as the child's primary/first language (key measures used in the study do not have alternate language versions).
- Attains a score equal to or less than 75% correct on the Ekman 60 Faces Test
- The parent who completes the questionnaires needs to be proficient in English.
- Has successfully played a video game using a Microsoft Xbox game controller, Sony PlayStation game controller, or other comparable game controller.
- Parental/guardian permission (informed consent) and if appropriate, child assent.
- Wi-Fi internet connection at subject's home/school/therapy center/research organization available for use by study laptop computer.
Exclusion Criteria:
- History of seizures.
- History of traumatic brain injury or other significant medical or neurological abnormality affecting motor or higher cortical functioning.
- Certain visual, auditory, DSM 5, or conduct disorders (see below).
- A visual disorder that cannot be corrected through the use of corrective lenses to a level of 20-40 in both eyes.
- Use of corrective visual lenses that would significantly impede the valid collection of visual attention and gaze pattern data during dyadic interaction tasks.
- Auditory impairment (that cannot be corrected by a hearing aid) that would significantly impede the valid collection of test measures.
- Profound intellectual disability or sensory-motor difficulties that would preclude valid use of diagnostic instruments and/or use of a computer or mobile computing device.
- A DSM 5 disorder or other psychiatric symptoms that would interfere with the participant's ability to participate in the study (e.g., active psychosis), per parent report.
- History of one or more psychiatric hospitalizations.
- Presence of significant symptoms of a conduct disorder.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Lookware TM
Lookware TM computer-based video game that requires the subject to engage in social skills related exercises during simulated social interactions with game characters.
|
Lookware TM is a computer-based video game that requires the subject engage in social skills related exercises that include certain visual behaviors.
These exercises combine techniques from applied behavior analysis (ABA) and use of gaze-contingent eye tracking technology during simulated social interactions with 3D animated characters to target certain social skills deficits in children with autism spectrum disorder (ASD).
The game is delivered through a laptop computer, eye tracker, and game controller.
|
Placebo Comparator: Lookware TM Control Module
Lookware TM Control Module is a version of the Lookware TM computer-based video game that excludes the social skills related exercises.
|
Lookware TM Control Module is a version of the Lookware TM computer-based video game that excludes the social skills related exercises.
The game is delivered through a laptop computer, eye tracker, and game controller.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ekman-60 Faces Test
Time Frame: 6 Weeks
|
The Ekman-60 Faces Test is used to assesses emotion recognition using pictures.
In this study, children were presented with 60 faces across 10 actors displaying six basic emotions (i.e., happiness, sadness, disgust, fear, surprise, and anger).
Facial expressions are displayed on the computer for five seconds, after which the image disappears, and participants select from a list of emotions which best described the facial expression shown.
Correct responses are summed to create a total score with a possible range from 0-60, and higher scores indicate better emotion recognition.
|
6 Weeks
|
Social Responsiveness Scale
Time Frame: 6 Weeks
|
The Social Responsiveness Scale is used to identify social impairment in children with autism spectrum disorder.
The measure consists of five subscales: social motivation; social awareness; social cognition; social communication; and restricted interests and repetitive behavior, each with items scored on a scale from 1 to 4. A total score can be computed by summing scores across subscales, including, or excluding the restricted interests and repetitive behavior subscale.
In this study, response options were re-coded from a scale of 1 to 4, to 0 to 3. Scores were then summed across four subscales, excluding the restrictive and repetitive behavior subscale.
Possible scores ranged from 0 to 195, with higher scores meaning a better outcome.
|
6 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Childhood Joint Attention Rating Scale
Time Frame: 6 Weeks
|
The Childhood Joint Attention Rating Scale is used to assess joint attention in children with autism spectrum disorder.
In this study, we used the asocial subscale, which consists of 14 items on a scale from 0 to 4. Scores were then summed, with a possible range from 0 to 56, and higher scores meant worse joint attention.
|
6 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 25, 2018
Primary Completion (Actual)
February 19, 2020
Study Completion (Actual)
February 19, 2020
Study Registration Dates
First Submitted
September 11, 2018
First Submitted That Met QC Criteria
September 13, 2018
First Posted (Actual)
September 14, 2018
Study Record Updates
Last Update Posted (Actual)
July 15, 2022
Last Update Submitted That Met QC Criteria
June 22, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 08012018A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on Lookware TM
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); Atrium...CompletedVentral Hernia | AdhesionsUnited States
-
NephroSantNot yet recruitingKidney Transplant Failure and Rejection
-
University Hospital TuebingenTerminatedApnea of Prematurity | Continuous Positive Airway Pressure | CPAP
-
Ivoclar Vivadent AGNot yet recruitingClass I or II Cavities in Premolars or Molars
-
Tufts UniversityBioElectronics CorporationTerminatedPostoperative Edema and PainUnited States
-
Boston UniversityNational Institute of Dental and Craniofacial Research (NIDCR)Not yet recruitingHIV Infections
-
BioTech Tools S.A.Completed
-
Zimmer BiometActive, not recruitingOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Revision Total Shoulder Arthroplasty | Ununited Humeral Head Fracture | Irreducible 3-and 4-part Proximal Humeral Fractures | Gross Rotator Cuff DeficiencyUnited States, United Kingdom
-
RWTH Aachen UniversityUniversity of ChicagoCompleted
-
University Hospital Inselspital, BerneEdwards LifesciencesCompletedVasodilation | Vasoconstriction | Hemodynamics | Cardiac Output, Low | Cardiac Output, HighSwitzerland